Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murray W Huff

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|October 23, 2003
Dietary cholesterol, cholesterol absorption, postprandial lipemia and atherosclerosisMurray W Huff
PPAR Research|June 16, 2012
Protection from Metabolic Dysregulation, Obesity, and Atherosclerosis by Citrus Flavonoids: Activation of Hepatic PGC1α-Mediated Fatty Acid OxidationErin E Mulvihill, Murray W Huff
Arteriosclerosis, Thrombosis, and Vascular Biology|February 27, 2015
Can a vascular smooth muscle-derived foam-cell really change its spots?Murray W Huff, J Geoffrey Pickering
Circulation Research|May 25, 2013
Apolipoprotein C-III: going back to the future for a lipid drug targetMurray W Huff, Robert A Hegele
Current Opinion in Lipidology|March 14, 2013
Peroxisome proliferator-activated receptor δ: a multifaceted metabolic playerLazar A Bojic, Murray W Huff
Arteriosclerosis, Thrombosis, and Vascular Biology|December 29, 2017
Knockdown of Δ-5 Fatty Acid Desaturase Is More Than Just a FadNadya M Morrow, Murray W Huff
Current Opinion in Investigational Drugs (London, England : 2000)|December 25, 2002
Avasimibe PfizerJohn R Burnett, Murray W Huff
Expert Opinion on Investigational Drugs|October 17, 2006
Cholesterol absorption inhibitors as a therapeutic option for hypercholesterolaemiaJohn R Burnett, Murray W Huff
Trends in Pharmacological Sciences|June 14, 2005
Lord of the rings--the mechanism for oxidosqualene:lanosterol cyclase becomes crystal clearMurray W Huff, Dawn E Telford
The Canadian Journal of Cardiology|April 14, 2010
Antiatherogenic properties of flavonoids: implications for cardiovascular healthErin E Mulvihill, Murray W Huff
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|October 23, 2003
Dietary cholesterol, cholesterol absorption, postprandial lipemia and atherosclerosisMurray W Huff
PPAR Research|June 16, 2012
Protection from Metabolic Dysregulation, Obesity, and Atherosclerosis by Citrus Flavonoids: Activation of Hepatic PGC1α-Mediated Fatty Acid OxidationErin E Mulvihill, Murray W Huff
Arteriosclerosis, Thrombosis, and Vascular Biology|February 27, 2015
Can a vascular smooth muscle-derived foam-cell really change its spots?Murray W Huff, J Geoffrey Pickering
Circulation Research|May 25, 2013
Apolipoprotein C-III: going back to the future for a lipid drug targetMurray W Huff, Robert A Hegele
Current Opinion in Lipidology|March 14, 2013
Peroxisome proliferator-activated receptor δ: a multifaceted metabolic playerLazar A Bojic, Murray W Huff
Arteriosclerosis, Thrombosis, and Vascular Biology|December 29, 2017
Knockdown of Δ-5 Fatty Acid Desaturase Is More Than Just a FadNadya M Morrow, Murray W Huff
Current Opinion in Investigational Drugs (London, England : 2000)|December 25, 2002
Avasimibe PfizerJohn R Burnett, Murray W Huff
Expert Opinion on Investigational Drugs|October 17, 2006
Cholesterol absorption inhibitors as a therapeutic option for hypercholesterolaemiaJohn R Burnett, Murray W Huff
Trends in Pharmacological Sciences|June 14, 2005
Lord of the rings--the mechanism for oxidosqualene:lanosterol cyclase becomes crystal clearMurray W Huff, Dawn E Telford
The Canadian Journal of Cardiology|April 14, 2010
Antiatherogenic properties of flavonoids: implications for cardiovascular healthErin E Mulvihill, Murray W Huff
Pageof 8